This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Evan R. Norris
Introduction
Evan R. Norris is a notable inventor based in Chappaqua, NY. He has made significant contributions to the field of medicine, particularly in the treatment of chemical dependencies. His innovative approach has garnered attention in the scientific community.
Latest Patents
Evan R. Norris holds a patent for a method of treating chemical dependencies using sertraline. This method involves administering an effective amount of the compound (1S-cis)-4-(3, 4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine, commonly known as sertraline, to a mammal in need of treatment. This innovative approach aims to reduce or alleviate chemical dependency.
Career Highlights
Evan R. Norris is associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to advancements in medical treatments and therapies. His dedication to research and development has positioned him as a valuable asset in the field.
Collaborations
Evan has collaborated with notable colleagues, including Nicholas G. Bacopoulos and Peter A. Blick. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Evan R. Norris exemplifies the spirit of innovation in the medical field through his patent and work at Pfizer Corporation. His contributions to treating chemical dependencies highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile